4//SEC Filing
Janku Filip 4
Accession 0000899243-22-008706
CIK 0001826457other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 6:46 PM ET
Size
5.4 KB
Accession
0000899243-22-008706
Insider Transaction Report
Form 4
Janku Filip
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-03-01+86,500→ 86,500 totalExercise: $13.41Exp: 2032-02-29→ Common Stock (86,500 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on January 1, 2023, with the remainder vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Monte Rosa Therapeutics, Inc.
CIK 0001826457
Entity typeother
Related Parties
1- filerCIK 0001862930
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 6:46 PM ET
- Size
- 5.4 KB